SUS offers insulin glargine for children, adolescents and the elderly

Until this Monday (13), the Ministry of Health had already sent more than 254 thousand cartridges of insulin glargine to 16 states. 52,350 reusable pens were also distributed to apply the medicine. All units of the Federation must receive the medicine by the end of July.

Access to the medicine will occur through clinical evaluation and medical prescription, with availability in Basic Health Units (UBSs) across the country.

Considered a more modern therapeutic option, insulin glargine has a prolonged action and, in most cases, requires only one daily application.

Other treatment regimens may require up to three applications in the same period.

According to the ministry, the use of insulin glargine provides more stable blood glucose control and reduces the risk of hypoglycemic episodes.

The expectation is that the change will provide greater safety and quality of life for patients cared for by the SUS.

Access

To access insulin glargine, the patient must look for the UBS closest to their home with a duly issued and stamped medical prescription.

In the case of children and adolescents, parents, guardians or caregivers can also request the replacement of NPH insulin with the new therapeutic option.

Users will be attended to by a multidisciplinary team, responsible for evaluating the clinical condition and verifying the possibility of treatment transition.

Along with insulin glargine, a reusable pen will be made available for application, valid for three years, in addition to the needles needed to administer the product.

Shortness of breath and tiredness? Understand when it could be heart failure

Extreme tiredness, shortness of breath, swelling and palpitations may indicate difficulty in pumping blood. The condition is chronic, requires medical monitoring and can have different levels of severity